Salveo backs cannabis biotech in $10m Series A

Managing partner Jeffrey Howard says Front Range Biosciences is among the companies benefiting from a surge in private investor interest in cannabis.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this